1. Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE
   Wencui Yang et al, 2021, Journal of Healthcare Engineering CrossRef
2. Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities
   Zixuan Gou et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
3. Dual effects of DLG5 (disks large homolog 5 gene) modulation on chemotherapy‐induced thrombocytopenia and nausea/vomiting via the hippo signalling pathway
   Mingming Li et al, 2024, British Journal of Pharmacology CrossRef
4. TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC
   Si-bo Yang et al, 2023, Biology Direct CrossRef
5. High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer
   Yuao Deng et al, 2021, Recent Patents on Anti-Cancer Drug Discovery CrossRef
6. Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer
   Longyang Liu et al, 2022, Frontiers in Molecular Biosciences CrossRef
7. The Long Non-Coding RNA FAM222A-AS1 Negatively Modulates MiR-Let-7f to Promote Colorectal Cancer Progression
   Mengmeng Song et al, 2022, Frontiers in Oncology CrossRef
8. Application of single cell sequencing technology in ovarian cancer research (review)
   Qiqolei Yuan et al, 2024, Functional & Integrative Genomics CrossRef
9. The mechanobiome: a goldmine for cancer therapeutics
   Eleana Parajón et al, 2021, American Journal of Physiology-Cell Physiology CrossRef
10. Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer
    Longyang Liu et al, 2021, Recent Patents on Anti-Cancer Drug Discovery CrossRef
11. Chromosome 22
    Sayooj Madhusoodanan et al, 2023, Cancer Genes: Volume 2 CrossRef